John Gillard PhD

VP Product Development, Kalgene Pharmaceuticals

Current board roles

NuChem Therapeutics

Previous board roles

IBEX Technologies
Canadian Genetic Disease Network
Kinetek Pharma

Education

PhD (Organic Chemistry) University of Tasmania, Australia
Post-doctoral studies in Organic Chemistry, Institut de Chimie des Substances Naturelles, France

Industry affiliations

Ottawa Life Sciences Council